Point72 Hong Kong’s Acutus Medical Inc AFIB Stock Holding History

Point72 Hong Kong’s Portfolio AFIB Stock Details AFIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,768	Closed	-$16K	–	2513
2021 Q3	$16K	Buy	+1,768	New	+$23.3K	﹤0.01%	1735

Other funds holding AFIB

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

KSCM

Kamunting Street Capital Management Miami Beach, Florida $183M AUM 2.19% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Point72 Hong Kong's AFIB Position: Q4 2021 in Review

Point72 Hong Kong sold out of Acutus Medical Inc (AFIB) in Q4 2021, closing a stake of 1,768 shares — an estimated $16K sold.

Point72 Hong Kong first reported a position in AFIB in Q3 2021 and held it in 1 quarter. The position peaked at $16K in Q3 2021. 71 funds tracked by Wall St. Rank hold AFIB as of Q4 2021.

Point72 Hong Kong reported no remaining Acutus Medical Inc position as of Q4 2021 after selling out during the quarter.
Point72 Hong Kong sold 1,768 Acutus Medical Inc shares in Q4 2021, an estimated $16K.
Point72 Hong Kong first reported a position in Acutus Medical Inc in Q3 2021 and held it in 1 quarter.
Point72 Hong Kong's Acutus Medical Inc position peaked at $16K in Q3 2021.
71 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q4 2021.

Based on Point72 Hong Kong's 13F filing for Q4 2021, filed 14 Feb 2022.